Wolfe Research Downgrades Centessa Pharmaceuticals to Peer Perform

Benzinga Newsdesk www.benzinga.com Negative 93.1%

Neg 93.1% Neu 0% Pos 0%

Wolfe Research analyst Rudy Li downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Outperform to Peer Perform.

Comments

No comments yet. Be the first!